Allianz Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,629
| Closed | -$144K | – | 2236 |
|
|
2023
Q1 | $144K | Buy |
13,629
+4,091
| +43% | +$124K | ﹤0.01% | 2054 |
|
|
2022
Q4 | $323K | Buy |
+9,538
| New | +$462K | ﹤0.01% | 1802 |
|
|
2022
Q1 | – | Sell |
-4,471
| Closed | -$910K | – | 2574 |
|
|
2021
Q4 | $910K | Buy |
4,471
+3,093
| +224% | +$671K | ﹤0.01% | 1946 |
|
|
2021
Q3 | $371K | Sell |
1,378
-333
| -19% | -$80.1K | ﹤0.01% | 2346 |
|
|
2021
Q2 | $441K | Hold |
1,711
| – | – | ﹤0.01% | 2096 |
|
|
2021
Q1 | $513K | Buy |
+1,711
| New | +$533K | ﹤0.01% | 1890 |
|
|
2020
Q4 | – | Sell |
-1,741
| Closed | -$433K | – | 1926 |
|
|
2020
Q3 | $433K | Sell |
1,741
-381
| -18% | -$120K | ﹤0.01% | 1634 |
|
|
2020
Q2 | $737K | Sell |
2,122
-375
| -15% | -$117K | ﹤0.01% | 1927 |
|
|
2020
Q1 | $669K | Sell |
2,497
-1,319
| -35% | -$408K | ﹤0.01% | 1949 |
|
|
2019
Q4 | $1.24M | Buy |
3,816
+3,042
| +393% | +$882K | ﹤0.01% | 2094 |
|
|
2019
Q3 | $211K | Sell |
774
-1,776
| -70% | -$651K | ﹤0.01% | 2618 |
|
|
2019
Q2 | $1.36M | Sell |
2,550
-106
| -4% | -$53.2K | ﹤0.01% | 2029 |
|
|
2019
Q1 | $1.34M | Buy |
2,656
+270
| +11% | +$160K | ﹤0.01% | 1982 |
|
|
2018
Q4 | $1.18M | Buy |
+2,386
| New | +$1.44M | ﹤0.01% | 1961 |
|
|
2018
Q3 | – | Sell |
-2,653
| Closed | -$1.94M | – | 2681 |
|
|
2018
Q2 | $1.94M | Sell |
2,653
-4,259
| -62% | -$4.91M | ﹤0.01% | 1957 |
|
|
2018
Q1 | $11M | Buy |
6,912
+747
| +12% | +$962K | 0.01% | 1209 |
|
|
2017
Q4 | $5.52M | Sell |
6,165
-1,062
| -15% | -$628K | ﹤0.01% | 1576 |
|
|
2017
Q3 | $2.6M | Buy |
7,227
+500
| +7% | +$156K | ﹤0.01% | 1902 |
|
|
2017
Q2 | $1.96M | Sell |
6,727
-1,220
| -15% | -$353K | ﹤0.01% | 1991 |
|
|
2017
Q1 | $2.78M | Buy |
7,947
+533
| +7% | +$120K | ﹤0.01% | 1868 |
|
|
2016
Q4 | $1.36M | Sell |
7,414
-5,766
| -44% | -$1.17M | ﹤0.01% | 2111 |
|
|
2016
Q3 | $3.35M | Sell |
13,180
-747
| -5% | -$192K | ﹤0.01% | 1784 |
|
|
2016
Q2 | $2.97M | Hold |
13,927
| – | – | ﹤0.01% | 1747 |
|
|
2016
Q1 | $2.87M | Buy |
13,927
+169
| +1% | +$32.5K | ﹤0.01% | 1651 |
|
|
2015
Q4 | $3.52M | Hold |
13,758
| – | – | ﹤0.01% | 1490 |
|
|
2015
Q3 | $2.26M | Hold |
13,758
| – | – | ﹤0.01% | 1563 |
|
|
2015
Q2 | $2.58M | Sell |
13,758
-37,729
| -73% | -$6.49M | ﹤0.01% | 1606 |
|
|
2015
Q1 | $8.49M | Buy |
51,487
+761
| +2% | +$156K | 0.01% | 1016 |
|
|
2014
Q4 | $11.8M | Sell |
50,726
-4,851
| -9% | -$1.04M | 0.01% | 898 |
|
|
2014
Q3 | $10.1M | Buy |
55,577
+3,988
| +8% | +$763K | 0.01% | 833 |
|
|
2014
Q2 | $9.92M | Sell |
51,589
-4,877
| -9% | -$863K | 0.01% | 738 |
|
|
2014
Q1 | $10.3M | Buy |
56,466
+7,586
| +16% | +$1.5M | 0.01% | 747 |
|
|
2013
Q4 | $8.32M | Sell |
48,880
-22,583
| -32% | -$3.64M | 0.01% | 797 |
|
|
2013
Q3 | $11.2M | Buy |
71,463
+35,003
| +96% | +$6.47M | 0.01% | 630 |
|
|
2013
Q2 | $6.32M | Buy |
+36,460
| New | +$5.59M | 0.01% | 800 |
|
Other funds holding NKTR
DTC
MAM
SCM
Allianz Asset Management's NKTR Position: Q2 2023 in Review
Allianz Asset Management sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 13,629 shares — an estimated $144K sold.
Allianz Asset Management first reported a position in NKTR in Q2 2013 and held it in 35 quarters. The position peaked at $11.8M in Q4 2014. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.
- Allianz Asset Management reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
- Allianz Asset Management sold 13,629 Nektar Therapeutics shares in Q2 2023, an estimated $144K.
- Allianz Asset Management first reported a position in Nektar Therapeutics in Q2 2013 and held it in 35 quarters.
- Allianz Asset Management's Nektar Therapeutics position peaked at $11.8M in Q4 2014.
- 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.
Based on Allianz Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.